Derek Cole Selected Research

HTI 042

9/2004

Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Derek Cole Research Topics

Disease

1	Fibrosis (Cirrhosis) 01/2020
1	Hypertrophy 01/2020
1	Atrial Fibrillation 02/2019
1	Hemorrhage 02/2019
1	Venous Thromboembolism 02/2019
1	Reperfusion Injury 03/2017
1	Polydipsia 05/2008
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2008
1	Neoplasms (Cancer) 09/2004

Drug/Important Bio-Agent (IBA)

1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2020
1	apixabanIBA 02/2019
1	RivaroxabanIBA 02/2019
1	AnticoagulantsIBA 02/2019
1	Mitogen-Activated Protein KinasesIBA 03/2017
1	MAP Kinase Kinase Kinase 5IBA 03/2017
1	N(1)- (6- chloroimidazo(2,1- b)(1,3)thiazole- 5- sulfonyl)tryptamineIBA 05/2008
1	HTI 042IBA 09/2004